Deutsche Bank analyst Pito Chickering raised the firm’s price target on Zimmer Biomet to $147 from $121 and keeps a Hold rating on the shares following the Q1 beat.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on ZBH:
- Zimmer Biomet price target raised to $153 from $137 at Truist
- BofA upgrades Zimmer Biomet to Neutral, says ‘no more fighting’ earnings upside
- Zimmer Biomet upgraded to Neutral from Underperform at BofA
- Zimmer Biomet price target raised to $150 from $130 at Canaccord
- Zimmer Biomet price target raised to $156 from $141 at RBC Capital
